Stay tuned and follow the latest
developments and news in Molecular Oncology.
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer • First results from the independent SWOG […]
Read More
PrIMe – “Precision Individualized Medicine”The new Genekor Medical S.A. PrIMe gene test with 500+ genes and the biomarkers MSI, TBM and PD-L1 in patients with solid tumors has been officially […]
Read More
The use of TMB mutation load detection as a biomarker for the selection of pembrolizumab (Keytruda™) as a treatment for adult and pediatric patients with unresectable or metastatic solid tumors […]
Read More
Every human body is different. So a pharmaceutical substance cannot have the same effect on all people. A treatment may be highly beneficial for one person and for another it […]
Read More
COMMUNITIES MAKE THE DIFFERENCE Each year, on 1 December, the world commemorates World AIDS Day. People around the world unite to show support for people living with HIV and to […]
Read More
Cancer has become an extremely common disease nowadays, which should not be surprising when almost every family seems to have people with a history of cancer. Based on the findings […]
Read More
The past few decades the identification of cancer biomarkers has become a major project in cancer research. A tumor marker is anything present in or produced by cancer cells or […]
Read More
Precision medicine is an innovative approach to patient care and it has become a reality in today’s scientific society. A better genetic understanding of each and every disease may be […]
Read More
Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body’s natural defenses to fight cancer. It uses substances made by the body or in a […]
Read More